Research Topics
Genomes and GenesSpecies | Deirdre HillSummaryAffiliation: University of New Mexico Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Method of detection and breast cancer survival disparities in Hispanic womenDeirdre A Hill
University of New Mexico Cancer Research and Treatment Center and Department of Internal Medicine, MSC 10 5550, 1 University of New Mexico, Albuquerque, NM 87131 0001, USA
Cancer Epidemiol Biomarkers Prev 19:2453-60. 2010..We determined whether survival differences between Hispanic and non-Hispanic women might be attributable to the method of detection, an independent breast cancer prognostic factor in previous studies...
Strengthening gynecologic cancer prevention studiesDeirdre A Hill
Department of Internal Medicine, Division of Epidemiology, University of New Mexico School of Medicine, 1 University of NM, Albuquerque, NM 87131 0001, USA
Obstet Gynecol Clin North Am 34:639-50, vii. 2007..Cancer prevention efforts have recently suffered some well-publicized and not-so-well publicized setbacks. The prominence of some of these findings should not overshadow well-established achievements and recent successes...- Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genesDeirdre A Hill
Cancer Center and Department of Internal Medicine, UNM School of Medicine, 1 University of New Mexico, MSC 10 5550, Albuquerque, NM 87131 0001, USA
Blood 108:3161-7. 2006..03) in the nonhomologous end joining (NHEJ)/V(D)J pathway. These NHEJ/V(D)J-related gene variants represent promising candidates for further studies of NHL etiology and require replication in other studies... - Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factorsDeirdre A Hill
Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
Blood 106:3358-65. 2005..The additional increased relative risk of breast cancer after RT for HL is unlikely to be larger among women with a family history of breast or ovarian cancer than among other women... - Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphomaLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
J Natl Cancer Inst 97:1428-37. 2005..We estimated this future risk, taking into account age and calendar year of HL diagnosis, HL treatment information, population breast cancer incidence rates, and competing causes of death... - Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal womenCatherine Schairer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS, Room 8020 MSC 7234, Rockville, MD 20852 7234, USA
Cancer Epidemiol Biomarkers Prev 14:1660-5. 2005..We sought to determine whether serum concentrations of estrogens, androgens, and sex hormone binding globulin in postmenopausal women were related to the presence of mammary hyperplasia, an established breast cancer risk factor... - Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin diseaseLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
JAMA 290:465-75. 2003..Quantitative associations between radiotherapy dose delivered to the breast and administered chemotherapy have not been reported to date in large series, nor has the influence of ovarian exposures on subsequent risk... - Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal womenCatherine Schairer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
Int J Cancer 108:773-9. 2004..5 (95% CI 0.7-3.0) and 1.6 (95% CI 0.8-3.2), respectively (p trend = 0.35 and 0.25, respectively). Our results suggest that insulin and insulin resistance may play a role in breast pathology in postmenopausal women... - Cancer in first-degree relatives and risk of glioma in adultsDeirdre A Hill
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892-7238, USA
Cancer Epidemiol Biomarkers Prev 12:1443-8. 2003..Shared environmental or genetic factors in families may influence glioma risk. Our findings suggest that individuals with a family history of specific cancers other than glioma may have an increased glioma risk... - Etiologic heterogeneity among non-Hodgkin lymphoma subtypesLindsay M Morton
Division of Cancer Epidemiology and Genetics, National Cancer Institute NCI, National Institutes of Health NIH, Rockville, MD, USA
Blood 112:5150-60. 2008.... - Pesticide use and breast cancer risk among farmers' wives in the agricultural health studyLawrence S Engel
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Am J Epidemiol 161:121-35. 2005..Further follow-up of this cohort should help clarify the relation between pesticide exposure and breast cancer risk... - Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapyJessica Chubak
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98195, USA
Cancer Causes Control 18:1001-7. 2007..It is unknown whether postmenopausal unopposed estrogen users are better off, in terms of endometrial cancer risk, switching to a combined estrogen-progestin regimen or stopping hormone use altogether... - Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer riskMichael Hauptmann
J Natl Cancer Inst 95:1251-2. 2003 - Risk factors for the incidence of endometrial cancer according to the aggressiveness of diseaseJocelyn M Weiss
Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Am J Epidemiol 164:56-62. 2006..In general, a woman's risk of endometrial cancer appears to be influenced by similar risk factors regardless of disease severity... - Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapyJames M Allan
Epidemiology and Genetics Unit, Department of Biology, University of York, York, United Kingdom, YO10 5YW
Blood 104:3872-7. 2004..22 for Gln/Gln vs Lys/Lys; 95% CI, 1.04-4.74). These data suggest that the XPD codon 751 glutamine variant protects against myeloid cell death after chemotherapy... - Medical radiation, family history of cancer, and benign breast disease in relation to breast cancer risk in young women, USADeirdre A Hill
Department of Preventive Medicine, University of Southern California, Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles 90033, USA
Cancer Causes Control 13:711-8. 2002..Some evidence suggests that such risk may be distinctly elevated among women with a family history of breast or ovarian cancer (probably only carriers of specific gene mutations) and women with benign breast disease (BBD)...
Research Grants
- Towards a Transdisciplinary Understanding of Breast Cancer Survival DisparitiesDeirdre Hill; Fiscal Year: 2010....